HomepageEarnings Events Newsdesk 4 hours ago Abbott Laboratories (ABT) New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test Abbott Laboratories (NYSE: ABT) FY 2026 Other Release Comfort Systems USA, Inc. (FIX) Q1 2026 Earnings Announcement » « Moderna, Inc (MRNA) Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or Metastatic Melanoma at the 2026 AACR Annual Meeting Newsdesk:
